[go: up one dir, main page]

WO2001038501A3 - Human serine protease - Google Patents

Human serine protease Download PDF

Info

Publication number
WO2001038501A3
WO2001038501A3 PCT/US2000/031819 US0031819W WO0138501A3 WO 2001038501 A3 WO2001038501 A3 WO 2001038501A3 US 0031819 W US0031819 W US 0031819W WO 0138501 A3 WO0138501 A3 WO 0138501A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
human serine
protease family
zfaix1
fibrinolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/031819
Other languages
French (fr)
Other versions
WO2001038501A2 (en
Inventor
James L Holloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU16245/01A priority Critical patent/AU1624501A/en
Publication of WO2001038501A2 publication Critical patent/WO2001038501A2/en
Publication of WO2001038501A3 publication Critical patent/WO2001038501A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Members of the serine protease family play a role in carefully controlled processes, such as blood coagulation, fibrinolysis, complement activation, fertilization, and hormone production. These enzymes are also used in a variety of diagnostic, therapeutic, and industrial contexts. Zfaix1 is a new member of the serine protease family.
PCT/US2000/031819 1999-11-23 2000-11-17 Human serine protease Ceased WO2001038501A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU16245/01A AU1624501A (en) 1999-11-23 2000-11-17 Human serine protease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44837699A 1999-11-23 1999-11-23
US09/448,376 1999-11-23

Publications (2)

Publication Number Publication Date
WO2001038501A2 WO2001038501A2 (en) 2001-05-31
WO2001038501A3 true WO2001038501A3 (en) 2002-02-21

Family

ID=23780070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/031819 Ceased WO2001038501A2 (en) 1999-11-23 2000-11-17 Human serine protease

Country Status (2)

Country Link
AU (1) AU1624501A (en)
WO (1) WO2001038501A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU785149B2 (en) * 1999-12-02 2006-10-05 Jens Christian Jensenius MASP-3, a complement-fixing enzyme, and uses for it
JP2004501612A (en) * 2000-03-17 2004-01-22 インサイト・ゲノミックス・インコーポレイテッド Protease
WO2002010404A2 (en) * 2000-07-27 2002-02-07 Bayer Aktiengesellschaft Regulation of human masp-like serine protease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040451A2 (en) * 1999-12-02 2001-06-07 Jens Christian Jensenius Masp-3, a complement-fixing enzyme, and uses for it

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040451A2 (en) * 1999-12-02 2001-06-07 Jens Christian Jensenius Masp-3, a complement-fixing enzyme, and uses for it

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; August 2000 (2000-08-01), DAHL M R ET AL: "Mannan-binding lectin associated serine protease 3 (MASP-3): A new component of the lectin pathway of complement activation.", XP002172893, Database accession no. PREV200000389401 *
DATABASE EMBL 30 June 1999 (1999-06-30), MUZNY D ET AL: "Homo sapiens 3q27 BAC RP11-208N14", XP002172894 *
IMMUNOPHARMACOLOGY, vol. 49, no. 1-2, August 2000 (2000-08-01), XVIIIth International Complement Workshop;Salt Lake City, Utah, USA; July 23-27, 2000, pages 79, ISSN: 0162-3109 *

Also Published As

Publication number Publication date
WO2001038501A2 (en) 2001-05-31
AU1624501A (en) 2001-06-04

Similar Documents

Publication Publication Date Title
TR199902692T2 (en) Serine protease inhibitors.
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
WO2000054799A3 (en) Medicament for treating diabetes
WO2001083782A3 (en) Novel proteases
WO2002000860A3 (en) Novel proteases
NO994858D0 (en) Compounds and preparations for the treatment of diseases associated with serine protease, especially tryptase activity
WO2001038501A3 (en) Human serine protease
EP1997510A8 (en) Non-neurotoxic plasminogen-activating factors for treating strokes
WO2001066771A3 (en) Human serine protease
EP0373771A3 (en) New pharmaceutical uses for cystatins
GB9216558D0 (en) Modified proteases
WO1999058098A8 (en) HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
AU2353688A (en) Modified tissue plasminogen activator
WO2001046230A3 (en) Kunitz domain polypeptide zkun11
AU695190B2 (en) Substance FA-70D, process for producing the same, and uses thereof
WO2002014359A3 (en) Human serpin zserp15
IE890270L (en) Proteins derived from human alpha 2 plasmin inhibitor
TW288046B (en) Nucleotide sequence of cDNA of a thrombin-like enzyme (ancrod) from Calloselasma rhodostoma and amino acid sequence of ancrod therefrom
WO2001038534A3 (en) Human serpin
AU9066198A (en) Use of bromelain proteases for inhibiting blood coagulation
SUMI et al. Enzymatic production of acid stable trypsin-plasmin inhibitor (ASTI) in human plasma
EP0957110A3 (en) Lyophilized tubulins
WO2002026949A3 (en) Human proteases and polynucleotides encoding the same
Highleyman Expanded access program begins
WO2001078765A3 (en) Prophylaxis and treatment of diabetes mellitus 1 using proteolytic enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)